One would think that a verdict of this magnitude would send a very loud, very clear message to Androgel maker AbbVie. Unfortunately, the testosterone therapy maker may actually escape paying on this verdict, calling into question whether the company will still “hear” the jury.
The $150 million testosterone verdict was just issued in the case of an Oregon man whose lawsuit accused AbbVie of hiding ...
continue reading...
We already know about the alleged link between testosterone therapy and heart attacks and stroke. Testosterone therapy lawsuits have been filed across the country as thousands of plaintiffs claim that the largely unnecessary treatment led to severe and, at times fatal, side effects.
Testosterone therapy has been developed and marketed as a way of treating a manufactured condition known as ‘Low T.’ It is a simple fact of ...
continue reading...
As we’ve seen with the opioid epidemic sweeping across the country, the more available a prescription drug becomes, the greater the potential seems to become for that prescription drug to be abused. As drug companies flood American cities and towns with more painkillers than they could possibly take under normally-prescribed conditions, the number of overdoses and deaths has skyrocketed.
Sadly, that same kind of dependency and abuse is now starting to show ...
continue reading...
Regardless of the controversies surrounding testosterone therapy and the associated lawsuits, many people assume that there is still, at least, an actual medical condition which warrants some kind of medical treatment with testosterone. A new suit filed against Life Time Fitness, however, may call cause some to rethink that assumption.
In 2014, Life Time Fitness chose a company called Low T Center as its partner to offer ...
continue reading...According to recent data from the U.S. Judicial Panel on Multidistrict Litigation, the number of testosterone therapy lawsuits pending in federal court has climbed to 3,238. The Illinois multidistrict litigation, established in June 2014, initially included just eight testosterone lawsuits.
Popular Low-T drugs like AndroGel, Axiron, and Testim are approved by the U.S. Food and Drug Administration (FDA) for use in men whose testosterone is low due ...
continue reading...Judge Matthew Kennelly of the U.S. District Court for the District of Northern Illinois has denied Belgian company Besins Healthcare’s motion to dismiss itself from a multidistrict testosterone litigation, the Cook County Record reports. Along with AbbVie, Besins is responsible for the manufacture of AndroGel, one of the leading brands of testosterone therapy that have been targeted in a massive multi-state litigation.
Testosterone ...
continue reading...
